INNOVUS PHARMA INC (INNV)

0.11
OTC Markets
Prev Close 0.11
Day Low/High 0.10 / 0.11
52 Wk Low/High 0.08 / 0.21
Exchange OTC Markets
Shares Outstanding 194.05B
Market Cap 21.15M
Div & Yield N.A. (N.A)

Latest News

Innovus Pharma Announces The Approval Of Its Product ProstaGorx™ In Canada For Benign Prostatic Hyperplasia ("BPH")

Innovus Pharma Announces The Approval Of Its Product ProstaGorx™ In Canada For Benign Prostatic Hyperplasia ("BPH")

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma To Exhibit Its FlutiCare® And AllerVarx™ Products At The American Thoracic Society Event In San Diego From Sunday, May 20, 2018 To Tuesday, May 22, 2018

Innovus Pharma To Exhibit Its FlutiCare® And AllerVarx™ Products At The American Thoracic Society Event In San Diego From Sunday, May 20, 2018 To Tuesday, May 22, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Launch Of Its Product Vesele® In Canada

Innovus Pharma Announces The Launch Of Its Product Vesele® In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals To Release Its First Quarter 2018 Financial Results On Monday, May 14, 2018

Innovus Pharmaceuticals To Release Its First Quarter 2018 Financial Results On Monday, May 14, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its March 31, 2018 first quarter financial results on Monday, May 14, 2018, after the close of the U.

Innovus Pharma Announces The Launch Of Its Hemorrhoid Drug Xyralid® In Canada

Innovus Pharma Announces The Launch Of Its Hemorrhoid Drug Xyralid® In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Expands Its Senior Management With The Addition Of Ryan Selhorn, CPA, As Its Vice President, Chief Financial Officer

Innovus Pharma Expands Its Senior Management With The Addition Of Ryan Selhorn, CPA, As Its Vice President, Chief Financial Officer

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe...

Innovus Pharmaceuticals Reports Record Annual Revenue For Fiscal 2017 Of $8.8 Million, Preliminary Q1 2018 Revenue Of $4.3 Million To $4.4 Million And Expects To Exit 2018 Profitable

Innovus Pharmaceuticals Reports Record Annual Revenue For Fiscal 2017 Of $8.8 Million, Preliminary Q1 2018 Revenue Of $4.3 Million To $4.4 Million And Expects To Exit 2018 Profitable

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced full year 2017 net revenue of $8.

Innovus Pharmaceuticals To Release Annual 2017 Financial Results, Preliminary First Quarter 2018 Revenues And Provide Corporate Update On Monday, April 2, 2018

Innovus Pharmaceuticals To Release Annual 2017 Financial Results, Preliminary First Quarter 2018 Revenues And Provide Corporate Update On Monday, April 2, 2018

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its December 31, 2017 annual financial results, its preliminary first quarter 2018 revenues and provide a...

Innovus Pharma To Present At The Sachs BioCapital USA Forum At The New York Academy Of Sciences

Innovus Pharma To Present At The Sachs BioCapital USA Forum At The New York Academy Of Sciences

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma's AllerVarx™ Receives Commercial Approval By Health Canada For The Reduction In Symptoms Of Seasonal Allergic Rhinitis

Innovus Pharma's AllerVarx™ Receives Commercial Approval By Health Canada For The Reduction In Symptoms Of Seasonal Allergic Rhinitis

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

CORRECTING and REPLACING Innovus Pharma Launches its New Brand, Logo and its Latest E-Commerce-Enhanced Content Website

CORRECTING and REPLACING Innovus Pharma Launches its New Brand, Logo and its Latest E-Commerce-Enhanced Content Website

First paragraph, second sentence should read: The new website can be found at innovuspharma.

Innovus Pharma Announces The Complete Repayment In Cash Of Its Financial Obligations From Its Acquisition Of Its Beyond Human® Assets

Innovus Pharma Announces The Complete Repayment In Cash Of Its Financial Obligations From Its Acquisition Of Its Beyond Human® Assets

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Announces The Publication Of A Successful Clinical Trial In Overactive Bladder And Urine Incontinence Patients For Its UriVarx® Product

Innovus Pharma Announces The Publication Of A Successful Clinical Trial In Overactive Bladder And Urine Incontinence Patients For Its UriVarx® Product

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Expands Its Sales Channels Through An Alliance With Wellmed, LP To Access Their Extensive Direct Mailing Network Of 500,000 Current Customers

Innovus Pharma Expands Its Sales Channels Through An Alliance With Wellmed, LP To Access Their Extensive Direct Mailing Network Of 500,000 Current Customers

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma's Apeaz™ Drug For Arthritis Pain Relief Approved For Commercialization In Canada As A Natural Health Product

Innovus Pharma's Apeaz™ Drug For Arthritis Pain Relief Approved For Commercialization In Canada As A Natural Health Product

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock

Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Signs Exclusive License And Distribution Agreement With Lavasta Pharma For ProstaGorx® In Certain Middle Eastern And North African Countries

Innovus Pharma Signs Exclusive License And Distribution Agreement With Lavasta Pharma For ProstaGorx® In Certain Middle Eastern And North African Countries

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Announces Official Launch Of Its Amazon®, Walmart®, EBay® And Wish® On-Line Stores With A Combined 116 Product SKUs

Innovus Pharma Announces Official Launch Of Its Amazon®, Walmart®, EBay® And Wish® On-Line Stores With A Combined 116 Product SKUs

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Hemorrhoid Drug Xyralid™ Receives Approval In Canada

Innovus Pharma Hemorrhoid Drug Xyralid™ Receives Approval In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Announces U.S. Food And Drug Administration Clearance Of Its UriVarx® Urinary Tract Infection Test Strips

Innovus Pharma Announces U.S. Food And Drug Administration Clearance Of Its UriVarx® Urinary Tract Infection Test Strips

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Enters Into License And Distribution Agreement With Acerus Pharmaceuticals For The Commercialization Of UriVarx® In Canada

Innovus Pharma Enters Into License And Distribution Agreement With Acerus Pharmaceuticals For The Commercialization Of UriVarx® In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Two Innovus Pharma Products Officially Listed In OTC Section Of The RED BOOK™

Two Innovus Pharma Products Officially Listed In OTC Section Of The RED BOOK™

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Files Application For The Commercialization Of ProstaGorx® For Benign Prostatic Hyperplasia ("BPH") As A Natural Health Product In Canada

Innovus Pharma Files Application For The Commercialization Of ProstaGorx® For Benign Prostatic Hyperplasia ("BPH") As A Natural Health Product In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Expands International Distribution By Signing An Exclusive Agreement In Peru With Pharma Solutions For Zestra®, Zestra Glide®, EjectDelay® And Sensum+®

Innovus Pharma Expands International Distribution By Signing An Exclusive Agreement In Peru With Pharma Solutions For Zestra®, Zestra Glide®, EjectDelay® And Sensum+®

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma's Partner Bio Task Receives Approval For Zestra® As A Cosmetic From The National Pharmaceutical Regulatory Agency, Ministry Of Health, Malaysia For Arousal And Desire

Innovus Pharma's Partner Bio Task Receives Approval For Zestra® As A Cosmetic From The National Pharmaceutical Regulatory Agency, Ministry Of Health, Malaysia For Arousal And Desire

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharmaceuticals Sponsors 10th Annual LD Micro Investor Conference To Be Held On December 5, 2017

Innovus Pharmaceuticals Sponsors 10th Annual LD Micro Investor Conference To Be Held On December 5, 2017

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio With New Patent For Its Sensum+® Product In Mexico

Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio With New Patent For Its Sensum+® Product In Mexico

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...